Meet Nushama, New York’s new operator of medically supervised psychedelic wellness clinics for sustained depression, anxiety, chronic pain, addiction and trauma-induced mood disorders relief.
Two Locations So Far
Currently at 1111 Park Avenue in Manhattan and 7401 4th Avenue in Brooklyn, with a Madison Ave HQ opening in September, Nushama provides professionally administered, high-dose ketamine intravenous and intramuscular treatments in a serene, safe environment.
The startup offers integration and access, collaborating with therapists, practitioners, and providers to support their clients’ treatment plans while connecting their own patients to mental health practitioners that meet their needs.
“Mental wellness has reached a tipping point in mainstream media and culture,” Jay Godfrey, co-founder of Nushama told Benzinga. “We want to make mental wellness available to everyone. We are working with world-renowned doctors, focused exclusively on patient care. While we provide a psychedelic journey that is well-documented to treat depression, PTSD, addiction, and pain conditions, many instances of trauma-related OCD, eating disorders, and IBS can also benefit.”
Encuentra nuestro contenido en Español en El Planteo:
- Ketamina: Todo lo que Siempe Quisiste Saber y Nunca te Animaste a Preguntar
- Canadá: Obra Social Cubrirá Tratamientos con Ketamina para la Depresión
Courtesy photo.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!